Faculty MEETING VENUE NH Hotel Vittorio Veneto Corso Italia, 1 - 00198 Roma Ph. +39 06.84951 Federico Bussolino Candiolo (TO) Yihai Cao Stockholm - S Giacomo Cartenì Napoli Andrea Casazza Leuven - B Saverio Cinieri Brindisi Pier Francesco Conte Padova Francesco Di Costanzo Firenze Giampietro Gasparini Roma Raffaella Giavazzi Milano Stefano Indraccolo Padova Roberto Labianca Bergamo Domenica Lorusso Milano Paolo Marchetti Roma Camillo Porta Pavia Maurizio Prato Trieste Giuseppe Procopio Milano Girolamo Ranieri Bari Alberto Sobrero Genova Giuseppe Toffoli Aviano (PN) ITALIAN CME (Continuing Medical Education) The Italian Ministry of Health allows no. 7 CME credits for Biologist, Chemists and Physician specialized in Oncology and Anatomopathology. - Provider Studio ER Congressi SRL - ID 828-80444 - Educational objective: LINEE GUIDE-PROTOCOLLI-PROCEDURE 210174 .ercongressi.it VI INTERNATIONAL CONFERENCE IN MEMORY OF JUDAH FOLKMAN TRANSLATIONAL STUDIES ON ANGIOGENESIS Rome, January 25, 2014 NH Hotel Vittorio Veneto President: Giampietro Gasparini Co-Chairs: Federico Bussolino, Yihai Cao SCIENTIFIC SECRETARIAT Daniela Mazzocco S.C. Oncologia A.C.O. San Filippo Neri, Roma Ph. +39 06.33062237 ORGANIZING SECRETARIAT Studio E.R. Congressi - Triumph Group Via Marconi, 36 - 40122 Bologna Ph. +39 051.4210559 - Fax +39 051.4210174 E-mail [email protected] www.ercongressi.it Requested Auspices A.C.O. San Filippo Neri AIOM – Associazione Italiana di Oncologia Medica AITBI Associazione Culturale G. Dossetti CIPOMO-Collegio Italiano dei Primari Oncologia Medici Ospedalieri Ordine Provinciale di Roma dei Medici–Chirurghi e degli Odontoiatri SIC – Società Italiana di Cancerologia SIMG – Società Italiana di Medicina Generale Program 9.20 a.m. Introduction G. Gasparini 9.30 - 10.00 a.m. Role of antiangiogenic therapy in advanced colorectal tumors A. Sobrero JANUARY 25, 2014 11.40 a.m. - 12.00 p.m. Therapy of liver metastasis: systemic and locoregional treatments G. Ranieri 12.00 - 12.20 p.m. New indications of antiangiogenic therapy in gastrointestinal cancers R. Labianca SESSION I – BREAST CANCER 12.20 - 12.40 p.m. Discussion 10.00 - 10.20 a.m. Overview on clinical trials with bevacizumab in breast cancer P. Marchetti 12.40 - 1.20 p.m. Lunch Chairman: P. Marchetti 10.20 - 10.40 a.m. New drugs and clinical challenges of antiangiogenic therapy in breast cancer G. Gasparini 10.40 - 11.00 a.m. Antiangiogenic therapy in triple negative breast cancer P.F. Conte 11.00 - 11.20 a.m. Discussion SESSION II – GASTROINTESTINAL CANCERS Chairman: R. Labianca 11.20 - 11.40 a.m. Sequential treatments: Which place for antiangiogenic therapy? F. Di Costanzo SESSION III – NANOTECHNOLOGIES IN ONCOLOGY Chairman: G. Gasparini 3.00 - 3.20 p.m. Sequential treatments G. Procopio 3.20 - 3.40 p.m. New antiagiogenic agents G. Cartenì 3.40 - 4.00 p.m. Discussion 4.00 - 4.20 p.m. LECTURE: New therapeutic strategies in ovarian cancer D. Lorusso SESSION V– TRANSLATIONAL RESEARCH ROUNDTABLE Chairman: F. Bussolino 1.20 - 1.40 p.m. Technologic aspects M. Prato 4.20 - 4.40 p.m. LECTURE: Mechanisms controlling the angiogenic pathways: Which relevance in the clinical setting? Y. Cao 1.40 - 2.00 p.m. Clinical applications G. Toffoli 4.40 - 5.00 p.m. Predictive factors Y. Cao, R. Giavazzi, S. Indraccolo 2.00 - 2.20 p.m. Clinical results with nab-paclitaxel S. Cinieri 5.00 - 5.30 p.m. New acquisitions from laboratory research F. Bussolino, A. Casazza 2.20 - 2.40 p.m. Discussion Conclusions G. Gasparini SESSION IV– RENAL CANCER Chairman: G. Cartenì 2.40 - 3.00 p.m. Overview on clinical trials with antiangiogenic agents C. Porta Judah Folkman